101 related articles for article (PubMed ID: 30954448)
1. C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.
Chen Y; Zheng Y; Iyer SR; Harders GE; Pan S; Chen HH; Ichiki T; Burnett JC; Sangaralingham SJ
J Mol Cell Cardiol; 2019 May; 130():140-150. PubMed ID: 30954448
[TBL] [Abstract][Full Text] [Related]
2. Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor.
Liu D; Ceddia RP; Zhang W; Shi F; Fang H; Collins S
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2307882120. PubMed ID: 37399424
[TBL] [Abstract][Full Text] [Related]
3. C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension.
Dabral S; Noh M; Werner F; Krebes L; Völker K; Maier C; Aleksic I; Novoyatleva T; Hadzic S; Schermuly RT; Perez VAJ; Kuhn M
Commun Biol; 2024 Jun; 7(1):693. PubMed ID: 38844781
[TBL] [Abstract][Full Text] [Related]
4. Bioinspired Oligo-Urethane Nanoparticles for Delivering Exogenous C-Type Natriuretic Peptide: Synthetic Biomaterial Nanocarrier Complexes and Their Interactions with Cardiac Myofibroblasts.
Siqueira NM; Chung S; Shrestha S; Zhong A; Caruso LL; Mirani B; Mirzaei Z; Simmons CA; Santerre JP
Biomacromolecules; 2023 Jul; 24(7):3149-3158. PubMed ID: 37344353
[TBL] [Abstract][Full Text] [Related]
5. MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.
Ma X; McKie PM; Iyer SR; Scott C; Bailey K; Johnson BK; Benike SL; Chen H; Miller WL; Cabassi A; Burnett JC; Cannone V
JACC Basic Transl Sci; 2024 Jan; 9(1):18-29. PubMed ID: 38362338
[TBL] [Abstract][Full Text] [Related]
6. C53 is a cross-kingdom conserved reticulophagy receptor that bridges the gap betweenselective autophagy and ribosome stalling at the endoplasmic reticulum.
Stephani M; Picchianti L; Dagdas Y
Autophagy; 2021 Feb; 17(2):586-587. PubMed ID: 33164651
[TBL] [Abstract][Full Text] [Related]
7. Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways.
Liu Z; Zhang X; Wang Y; Tai Y; Yao X; Midgley AC
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627244
[TBL] [Abstract][Full Text] [Related]
8. Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation.
Ma X; Iyer SR; Ma X; Reginauld SH; Chen Y; Pan S; Zheng Y; Moroni DG; Yu Y; Zhang L; Cannone V; Chen HH; Ferrario CM; Sangaralingham SJ; Burnett JC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239899
[TBL] [Abstract][Full Text] [Related]
9. CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2.
Cachorro E; Günscht M; Schubert M; Sadek MS; Siegert J; Dutt F; Bauermeister C; Quickert S; Berning H; Nowakowski F; Lämmle S; Firneburg R; Luo X; Künzel SR; Klapproth E; Mirtschink P; Mayr M; Dewenter M; Vettel C; Heijman J; Lorenz K; Guan K; El-Armouche A; Wagner M; Kämmerer S
Circ Res; 2023 Feb; 132(4):400-414. PubMed ID: 36715019
[TBL] [Abstract][Full Text] [Related]
10. Localization of natriuretic peptide receptors A, B, and C in healthy and diseased mouse kidneys.
Heinl ES; Broeker KA; Lehrmann C; Heydn R; Krieger K; Ortmaier K; Tauber P; Schweda F
Pflugers Arch; 2023 Mar; 475(3):343-360. PubMed ID: 36480070
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptide pathways in heart failure: further therapeutic possibilities.
Sangaralingham SJ; Kuhn M; Cannone V; Chen HH; Burnett JC
Cardiovasc Res; 2023 Feb; 118(18):3416-3433. PubMed ID: 36004816
[TBL] [Abstract][Full Text] [Related]
12. Purification, characterization, and preliminary serial crystallography diffraction advances structure determination of full-length human particulate guanylyl cyclase A receptor.
Zhang S; Hansen DT; Martin-Garcia JM; Zook JD; Pan S; Craciunescu FM; Burnett JC; Fromme P
Sci Rep; 2022 Jul; 12(1):11824. PubMed ID: 35821229
[TBL] [Abstract][Full Text] [Related]
13. The CNP/NPR-B/cGMP Axis is a Therapeutic Target in Calcific Aortic Stenosis.
Armstrong DWJ; Gupta DK; Lindman BR; Merryman WD
JACC Basic Transl Sci; 2021 Dec; 6(12):1003-1006. PubMed ID: 35024506
[No Abstract] [Full Text] [Related]
14. Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators.
Sangaralingham SJ; Whig K; Peddibhotla S; Kirby RJ; Sessions HE; Maloney PR; Hershberger PM; Mose-Yates H; Hood BL; Vasile S; Pan S; Zheng Y; Malany S; Burnett JC
Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34930837
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure.
Ma X; Chen Y; Reginauld SH; Scott CG; Iyer SR; Schaefer JJ; Ichiki T; Chen HH; Rule AD; Burnett JC; Sangaralingham SJ
JACC Heart Fail; 2021 Sep; 9(9):613-623. PubMed ID: 34246604
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies.
Ghatage T; Goyal SG; Dhar A; Bhat A
Hypertens Res; 2021 Jul; 44(7):740-755. PubMed ID: 33731923
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic Peptides, Inflammation, and Sounding the Alarm.
Ramakrishnan V; Burnett JC
Circ Heart Fail; 2020 Jul; 13(7):e007208. PubMed ID: 32611204
[No Abstract] [Full Text] [Related]
18. Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.
Savira F; Magaye R; Liew D; Reid C; Kelly DJ; Kompa AR; Sangaralingham SJ; Burnett JC; Kaye D; Wang BH
Br J Pharmacol; 2020 Jul; 177(13):2906-2922. PubMed ID: 32250449
[TBL] [Abstract][Full Text] [Related]
19. Long-term blood pressure lowering and cGMP-activating actions of the novel ANP analog MANP.
Chen Y; Schaefer JJ; Iyer SR; Harders GE; Pan S; Sangaralingham SJ; Chen HH; Redfield MM; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2020 Apr; 318(4):R669-R676. PubMed ID: 32022596
[TBL] [Abstract][Full Text] [Related]
20. Discovery of
Hansen LH; Madsen TD; Goth CK; Clausen H; Chen Y; Dzhoyashvili N; Iyer SR; Sangaralingham SJ; Burnett JC; Rehfeld JF; Vakhrushev SY; Schjoldager KT; Goetze JP
J Biol Chem; 2019 Aug; 294(34):12567-12578. PubMed ID: 31186350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
